Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Psilocybin on Anxiety and Psychosocial Distress in Cancer Patients

NCT00957359 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.

NCT NCT00957359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00957359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Psilocybin on Anxiety and Psychosocial Distress in Cancer Patients
Lead sponsor
NYU Langone Health
Phase
Phase 1
Overall status
Completed
Start date
February 28, 2009
Completion date
September 6, 2018
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer